These germs include those that cannot be killed by all or most antibiotics, are not common to a geographic area or the U.S., or have specific genes that enable them to spread their resistance to other germs, according to a CDC release.

Healthcare facilities must ensure that infection prevention and control and antibiotic stewardship programs work together, according to a joint position paper released last week by the Association for Professionals in Infection Control and Epidemiology, the Society for Healthcare Epidemiology of America, and the Society of Infectious Disease Pharmacists.

The lawsuit was filed by the husband of Carol Leonard, who died at the age of 70 from a postoperative infection sustained during what was supposed to be a routine procedure.

Published in Nature this week, the study identified two compounds called synthetic retinoids that can help the body fight against methicillin-resistant Staphylococcus Aureus (MRSA).

The devastating flu season has started to wane, but the CDC’s weekly surveillance report found that the previously prevalent A-strain H3N2 flu virus is now less reported than B viruses.

A new study finds that in addition to being a deadly killer of patients, antibiotic-resistant infections are costing U.S. hospitals more than $2 billion each year.

Among the most common hospital-acquired infections, NV-HAP leads to significant increases in cost, length of stay, and mortality.